CAS RN: 217500-96-4

Tulathromycin A

Product Availability

Choose a grade to view its available package options.

11 package records10 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250714 1ml Out of stock 8-10 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260209 100mg In stock Shanghai Inquiry
Batchno.20251217 10mg In stock Shanghai Inquiry
Batchno.20250829 1g In stock Shanghai, Shenzhen Inquiry
Batchno.20250429 1mg In stock Shanghai Inquiry
Batchno.20250524 250mg In stock Shanghai Inquiry
Batchno.20260417 25g In stock Shanghai Inquiry
Batchno.20250825 50mg In stock Shanghai Inquiry
Batchno.20260318 5g In stock Shanghai Inquiry
Batchno.20250101 5mg In stock Shanghai Inquiry
Batchno.20250609 5mg / 25mg / 100mg / 500mg Confirm by inquiry Shanghai, Shandong, Guangdong Inquiry
  • Product code: SSC-105041
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 217500-96-4
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥95% 0 Out of Stock Hong Kong Inquiry

217500-96-4 / (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)oxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

Standard CAS: 217500-96-4 Multi CAS: No

Basic Information

CAS
217500-96-4
Multi CAS
No
Molecular Formula
C41H79N3O12
Molecular Weight
806.100000
Exact Mass
805.566375
SMILES
CCCNC[C@@]1([C@@H](O[C@H](C[C@@]1(C)OC)O[C@H]2[C@@H]([C@H]([C@](C[C@H](CN[C@@H]([C@H]([C@]([C@H](OC(=O)[C@@H]2C)CC)(C)O)O)C)C)(C)O)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)C)C)O
InChI
InChI=1S/C41H79N3O12/c1-15-17-42-22-41(50)28(8)53-31(20-39(41,10)51-14)55-33-25(5)35(56-37-32(45)29(44(12)13)18-24(4)52-37)38(9,48)19-23(3)21-43-27(7)34(46)40(11,49)30(16-2)54-36(47)26(33)6/h23-35,37,42-43,45-46,48-50H,15-22H2,1-14H3/t23-,24-,25+,26-,27-,28+,29+,30-,31+,32-,33+,34-,35-,37+,38-,39-,40-,41+/m1/s1
InChIKey
GUARTUJKFNAVIK-QPTWMBCESA-N

Computed Properties

Structural Parameters

Heavy atom count
56
Fraction Csp3
0.98
Rotatable bonds
11
H-bond acceptors
15
H-bond donors
7
Molar refractivity
211.66
TPSA
200.9

LogP / Solubility

WLOGP
1.93
MLOGP
1.77
XLogP3
3.8
Consensus LogP
2.5
Log S (ESOL)
-5.33
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.56
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.82
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.27

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us